References

Chang, C.Z., S.C. Wu, A.L. Kwan and C.L. Lin, 2015. Preconditioning with pitavastatin, an HMG-CoA reductase inhibitor, attenuates C-Jun N-terminal kinase activation in experimental subarachnoid hemorrhage-induced apoptosis. Acta. Neurochir., 157: 1031-1041.

Hattori, R., H. Otani, N. Maulik and D.K. Das, 2002. Pharmacological preconditioning with resveratrol: Role of nitric oxide. American J. Physiol. Heart Circulatory Physiol., 282: H1988-H1995.
CrossRef  |  Direct Link  |  

Kolesnik, I.M., M.V. Pokrovskiy, O.S. Gudyrev, L.M. Danilenko and A.E. Korolev et al., 2010. Distant and pharmacological preconditioning: New possibilities of neovasculogenesis stimulation. Kuban Res. Med. Gazette, 6: 56-58.

Matsumura, K., R.W. Jeremy, J. Schaper and L.C. Becker, 1998. Progression of myocardial necrosis during reperfusion of is chemic myocardium. Circulation, 97: 795-804.
CrossRef  |  Direct Link  |  

Mikhin, V.P., M.V. Pokrovskiy, V.V. Gureev, O.A. Chernova, U.V. Alimenko and E.N. Bogoslovskaya, 2011. Efficiency of a home-produced myocardial cytoprotector and its pharmacodynamics in case of acute myocardial ischemia: Clinical results and experimental models. Russ. Cardiol. J., 2: 37-42.

Pokrovskiy, M.V., T.V. Ostashko, K.V. Sarajan, Z.S. Lisovaya, T.A. Denisuk and N.N. Honcharov, 2014. Resveratrol, hawthorn extract, dihydroquercetinum, rosuvastatinum: Common way of cardioprotective effect realization. Res. J. Pharm. Biol. Chem. Sci., 5: 1453-1455.

Ravingerova, T., V. Ledvenyiova-Farkasova, M. Ferko, M. Bartekova and I. Bernatova et al., 2015. Pleiotropic preconditioning-like cardioprotective effects of hypolipidemic drugs in acute ischemia-reperfusion in normal and hypertensive rats. Can. J. Physiol. Pharmacol., 26: 1-9.

Skyschally, A., R. Schulz and G. Heusch, 2008. Pathophysiology of myocardial infarction: Protection by ischemic pre- and post-conditioning. Heart Cardiovasc. Dis., 33: 88-100.
CrossRef  |  Direct Link  |  

Swaminathan, J.K., M. Khan, I.K. Mohan, K. Selvendiran and S.N. Devaraj et al., 2010. Cardioprotective properties of Crataegus oxycantha extract against ischemia-reperfusion injury. Phytomedicine, 17: 744-752.
CrossRef  |  PubMed  |  Direct Link  |  

Vale, N., A.J. Nordmann, G.G. Schwartz, J. de Lemos and F. Colivicchi et al., 2011. Statins for acute coronary syndrome. Cochrane Lib., 10.1002/14651858.CD006870.pub2